Skip Nav Destination
Close Modal
Search Results for
prescription
Update search
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-20 of 862
Search Results for prescription
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Article
J Health Polit Policy Law (1984) 9 (3): 527–529.
Published: 01 June 1984
...Ronald C. Lippincott Henry J. Aaron and William B. Schwartz, The Painful Prescription: Rationing Hospital Care (Washington, D.C.: The Brookings Institution, 1984), 161 pp., $22.95 Copyright © 1984 by the Department of Health Administration, Duke University 1984 Henry J. Aaron...
Journal Article
J Health Polit Policy Law (1994) 19 (4): 919–921.
Published: 01 August 1994
...Mark A. Hall Paul Jesilow, Henry N. Pontell, and Gilbert Geis. Prescription for Profit: How Doctors Defraud Medicaid . Berkeley, CA: University of California Press, 1993. 218 pp. $25.00 cloth. Copyright © 1994 by Duke University Press 1994...
Journal Article
J Health Polit Policy Law (1994) 19 (4): 922–924.
Published: 01 August 1994
...Kenneth I. Kaitin Milton Silverman, Mia Lydecker, and Philip R. Lee. Bad Medicine: The Prescription Drug Industry in the Third World . Stanford, CA: Stanford University Press, 1992. 358 pp. $29.95 cloth. Copyright © 1994 by Duke University Press 1994 922 Journal of Health Politics...
Journal Article
J Health Polit Policy Law (2000) 25 (5): 815–844.
Published: 01 October 2000
...Robin D. C. Gauld This article discusses events that led up to and the aftermath of New Zealand's radical health sector restructuring of 1993. It suggests that“big bang” policy change facilitated the introduction of a set of market-oriented ideas describable as a policy prescription. In general...
Journal Article
J Health Polit Policy Law (2013) 38 (3): 475–477.
Published: 01 June 2013
... . www.nytimes.com/roomfordebate/2012/02/15/how-to-curb-prescription-drug-abuse . Sabet Kevin A. 2012 . “How to Treat the Epidemic.” New York Times , February 15 . www.nytimes.com/roomfordebate/2012/02/15/how-to-curb-prescription-drug-abuse/how-to-treat-the-prescription-drug-epidemic...
Journal Article
J Health Polit Policy Law (1998) 23 (2): 395–396.
Published: 01 April 1998
...Peter Temin Peter Davis, ed. Contested Ground: Public Purpose and Private Interest in the Regulation of Prescription Drugs. New York: Oxford University Press, 1996. 262 pp. $39.95 cloth. Copyright © 1998 by Duke University Press 1998 Reviews...
View articletitled, Contested Ground: Public Purpose and Private Interest in the Regulation of <span class="search-highlight">Prescription</span> Drugs
View
PDF
for article titled, Contested Ground: Public Purpose and Private Interest in the Regulation of <span class="search-highlight">Prescription</span> Drugs
Journal Article
J Health Polit Policy Law (2021) 46 (4): 599–609.
Published: 01 August 2021
.... Among these competing priorities is the issue of access to and affordability of prescription drugs. Here, the authors outline Biden's plan for directly lowering prescription drug spending for payers and patients and for expanding access to prescription medications through improved health insurance...
Journal Article
J Health Polit Policy Law (2021) 46 (6): 1053–1068.
Published: 01 December 2021
...Rachel E. Sachs Abstract Throughout his four years in office, President Trump made prescription drug pricing a focus of his policy agenda. President Trump not only used strong language to criticize the pharmaceutical industry and its practices but also introduced ambitious reform policies that had...
View articletitled, The Rhetorical Transformations and Policy Failures of <span class="search-highlight">Prescription</span> Drug Pricing Reform under the Trump Administration
View
PDF
for article titled, The Rhetorical Transformations and Policy Failures of <span class="search-highlight">Prescription</span> Drug Pricing Reform under the Trump Administration
Journal Article
J Health Polit Policy Law (2022) 47 (4): 523–526.
Published: 01 August 2022
...Joseph White [email protected] Feldman, Robin . Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices . New York : Cambridge University Press , 2019 . 186 pp. $29.95 cloth. Copyright © 2022 by Duke University Press 2022...
View articletitled, Drugs, Money, and Secret Handshakes: The Unstoppable Growth of <span class="search-highlight">Prescription</span> Drug Prices
View
PDF
for article titled, Drugs, Money, and Secret Handshakes: The Unstoppable Growth of <span class="search-highlight">Prescription</span> Drug Prices
Journal Article
J Health Polit Policy Law (2022) 47 (6): 621–628.
Published: 01 December 2022
... for a century, rising prices have forced many people with diabetes in the United States to ration that essential medication (Fralick and Kesselheim 2019 ). Medicare enrollees often do not fill prescriptions for cancer and other specialty drugs because of the costs they face as a result of high prices...
Journal Article
J Health Polit Policy Law (2007) 32 (2): 187–219.
Published: 01 April 2007
...Jonathan Oberlander The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) represents a watershed event in Medicare politics. This essay explores the political lessons and policy legacies of the MMA, focusing on how the MMA fits with and deviates from established patterns...
View articletitled, Through the Looking Glass: The Politics of the Medicare <span class="search-highlight">Prescription</span> Drug, Improvement, and Modernization Act
View
PDF
for article titled, Through the Looking Glass: The Politics of the Medicare <span class="search-highlight">Prescription</span> Drug, Improvement, and Modernization Act
Journal Article
J Health Polit Policy Law (2019) 44 (1): 157–164.
Published: 01 February 2019
...Scott L. Greer Ezekiel J. Emanuel . Prescription for the Future: The Twelve Transformational Practices of Highly Effective Medical Organizations . New York : PublicAffairs , 2017 . 272 pages. $18.99 cloth. Copyright © 2019 by Duke University Press 2019 Ezekiel J. Emanuel has...
View articletitled, <span class="search-highlight">Prescription</span> for the Future: The Twelve Transformational Practices of Highly Effective Medical Organizations
View
PDF
for article titled, <span class="search-highlight">Prescription</span> for the Future: The Twelve Transformational Practices of Highly Effective Medical Organizations
Journal Article
J Health Polit Policy Law (2008) 33 (6): 1079–1106.
Published: 01 December 2008
...Austin B. Frakt; Steven D. Pizer; Ann M. Hendricks Medicare and the Veterans Health Administration (VA) both finance large outpatient prescription drug programs, though in very different ways. In the ongoing debate on how to control Medicare spending, some suggest that Medicare should negotiate...
View articletitled, Controlling <span class="search-highlight">Prescription</span> Drug Costs: Regulation and the Role of Interest Groups in Medicare and the Veterans Health Administration
View
PDF
for article titled, Controlling <span class="search-highlight">Prescription</span> Drug Costs: Regulation and the Role of Interest Groups in Medicare and the Veterans Health Administration
Journal Article
J Health Polit Policy Law (2011) 36 (2): 295–316.
Published: 01 April 2011
...Patricia M. Danzon; Scott J. Johnson; Genia Long; Michael F. Furukawa The option of legalizing the commercial importation of prescription drugs is of continued policy interest as a way to reduce U.S. drug spending. Using IMS data, we estimate potential savings from commercial drug importation under...
View articletitled, Commercial Importation of <span class="search-highlight">Prescription</span> Drugs in the United States: Short-Run Implications
View
PDF
for article titled, Commercial Importation of <span class="search-highlight">Prescription</span> Drugs in the United States: Short-Run Implications
Image
in Hydroxychloroquine for COVID-19: Variation in Regional Political Preferences Predicted New Prescriptions after President Trump's Endorsement
> Journal of Health Politics, Policy and Law
Published: 01 August 2022
Figure 1 Mean weekly hydroxychloroquine retail prescription rates in the top 20 and the bottom 20 Trump-voting DMAs, July 2019–July 2020.
More
Image
in Hydroxychloroquine for COVID-19: Variation in Regional Political Preferences Predicted New Prescriptions after President Trump's Endorsement
> Journal of Health Politics, Policy and Law
Published: 01 August 2022
Figure 2 Mean weekly hydroxychloroquine and ciprofloxacin retail prescription rates across 205 DMAs, July 2019–July 2020. Note : DMA = designated market area.
More
Journal Article
J Health Polit Policy Law (2022) 47 (4): 429–451.
Published: 01 August 2022
...Figure 1 Mean weekly hydroxychloroquine retail prescription rates in the top 20 and the bottom 20 Trump-voting DMAs, July 2019–July 2020. ...
FIGURES
View articletitled, Hydroxychloroquine for COVID-19: Variation in Regional Political Preferences Predicted New <span class="search-highlight">Prescriptions</span> after President Trump's Endorsement
View
PDF
for article titled, Hydroxychloroquine for COVID-19: Variation in Regional Political Preferences Predicted New <span class="search-highlight">Prescriptions</span> after President Trump's Endorsement
Image
in Rationing by Inconvenience: How Insurance Denials Induce Administrative Burdens
> Journal of Health Politics, Policy and Law
Published: 01 August 2024
Figure 1 Cigna prescriptions requiring prior authorization, 2016–2022.
More
Journal Article
J Health Polit Policy Law (2010) 35 (5): 705–742.
Published: 01 October 2010
... of outpatient prescription drugs is not. To solve problems of access, Canadian provinces have introduced provincial prescription drug benefit programs. This study analyzes the prescription drug policymaking process in five Canadian provinces between 1992 and 2004 with a view to (1) determining the federal...
Journal Article
J Health Polit Policy Law (2014) 39 (2): 295–330.
Published: 01 April 2014
...Jamie R. Daw; Steven G. Morgan; Patricia A. Collins; Julia Abelson Abstract Canada is the only country in the world to offer universal comprehensive public health insurance that excludes outpatient prescription medicines. Few scholars have attempted to explain this policy puzzle. We study media...
1